Dose-ranging study

From WikiMD's WELLNESSPEDIA

(Redirected from Dose-escalation study)

Dose-ranging study is a type of clinical trial where different doses of an investigational drug are tested to establish the dose which is both safe and effective. The main goal of a dose-ranging study is to determine the dose-response relationship of a new drug.

Overview[edit]

In a dose-ranging study, multiple doses of a drug are tested in parallel to evaluate the pharmacological effect at different dose levels. This type of study is typically performed in the early phases of clinical development after initial safety of the drug has been established through Phase I trials. The results of dose-ranging studies are used to establish the optimal dose for subsequent Phase III trials.

Design[edit]

The design of a dose-ranging study can vary depending on the drug and disease in question. However, most dose-ranging studies are randomized, double-blind, and placebo-controlled. Participants are randomly assigned to different dose groups, including a placebo group. The investigators and participants are blinded to the treatment assignments.

Outcome Measures[edit]

The primary outcome measure in a dose-ranging study is usually a biomarker or clinical endpoint that can be measured in a relatively short time. The choice of outcome measure depends on the drug and disease in question. The dose-response relationship is then established based on the observed changes in the outcome measure across the different dose groups.

Limitations[edit]

One of the main limitations of dose-ranging studies is that they are usually conducted in a relatively small number of participants and over a short period of time. Therefore, they may not detect all possible side effects of a drug, especially those that occur infrequently or over a long period of time. Furthermore, the dose-response relationship established in a dose-ranging study may not necessarily predict the long-term effectiveness or safety of the drug.

See Also[edit]



Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Medical weight loss NYC | Affordable GLP-1 injections NYC | Budget GLP-1 weight loss shots Philadelphia | New Jersey medical weight loss | NYC medical weight loss | Philadelphia medical weight loss | Sleep clinic NYC | W8MD's Philadelphia GLP-1 doctor | Weight loss prescriptions NYC

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.